Skip to ContentGo to accessibility page

Chapter 37

Review Questions

1.
a. The most important action for a nurse caring for transgender and nonbinary clients is to self-assess their own personal attitudes, beliefs, and feelings regarding these clients.
2.
c. This is an intended effect of hormonal therapy for individuals undergoing MTF transition.
3.
b. This is the only condition listed that is not a contraindication for testosterone therapy.
4.
c. Hypertension is often treated with ACE inhibitors or angiotensin receptor blockers, which could cause hyperkalemia when given concomitantly with spironolactone.
5.
b. Hyperkalemia is the most common and most serious adverse effect of spironolactone. Cardiac dysrhythmias and muscle cramps are indications of hyperkalemia and should be reported.
6.
a. Finasteride is highly toxic to a fetus. Any female who is pregnant or of childbearing age should avoid contact with this medication, especially if the tablet is broken or crushed.
7.
a. Testosterone therapy cannot be started in a pregnant client because of the dangers to the fetus.
8.
b. A client transitioning from female to male who has not had gender-affirming surgery still has female organs and still needs regular screenings for cervical and breast cancer.
9.
d. Spironolactone is an androgen blocker but does not block testosterone. Because the client is unsure about whether to transition, spironolactone is an appropriate choice because changes in sexual characteristics with spironolactone are reversible.
10.
b. Androgens may decrease blood glucose levels; therefore, any hypoglycemic medication is likely to need a dosage adjustment.
Citation/Attribution
Reuse and redistribution of this content in digital or print format:
  • This book may not be used in the training of large language models or otherwise be ingested into large language models or generative AI offerings without OpenStax's prior written permission.
  • This book uses the Creative Commons Attribution-NonCommercial-ShareAlike License, which means that you can reuse and modify the material only for noncommercial purposes, must attribute OpenStax, and must distribute any derivative works under the same license.
  • Any commercial printing of this textbook, including using a local or custom printer, must be approved by OpenStax, and proper citation provided.
  • OpenStax-copyrighted images, activities, assessments, and similar components of this book are subject to the same licensing – CC-BY-NC-SA. They can be used for noncommercial purposes with attribution. Commercial use requires permission.
  • Permission requests: Anyone who intends to incorporate this content (including text, images, and other components) into large language models, use it in AI offerings, use it commercially (including in print), and/or has questions about another use case is welcome to complete our reuse request form.
Attribution information
  • If you are redistributing all or part of this book in a noncommercial print format, then you must include on every physical page the following attribution:

    Access for free at https://openstax.org/books/pharmacology/pages/1-introduction

  • If you are redistributing all or part of this book in a noncommercial digital format, then for every page that includes OpenStax content, you must license the derivative work under the same CC-BY-NC-SA license as the original, and include on every digital page view the following attribution:

    Access for free at https://openstax.org/books/pharmacology/pages/1-introduction

Citation information

The information below includes the information needed to generate citations in most major styles (APA, MLA, etc.); you must reformat and organize the information as needed to fit the requirements of the style. Use the information below to generate a citation. We recommend using a citation tool such as this one.

© Apr 23, 2026 OpenStax. Textbook content produced by OpenStax is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike License. The OpenStax name, OpenStax logo, OpenStax book covers, OpenStax CNX name, and OpenStax CNX logo, and Rice University name, and Rice University logo trademarks, or wordmarks are not subject to the Creative Commons license and may not be reproduced without the prior and express written consent of Rice University.